TY - JOUR
T1 - Sinonasal Osteosarcoma
T2 - Report of 14 New Cases and Systematic Review of the Literature
AU - Low, Christopher M.
AU - Gruszczynski, Nelson R.
AU - Moore, Eric J.
AU - Price, Daniel L.
AU - Janus, Jeffrey R.
AU - Kasperbauer, Jan L.
AU - Van Abel, Kathryn M.
AU - Stokken, Janalee K.
AU - Van Gompel, Jamie J.
AU - Link, Michael J.
AU - Choby, Garret
N1 - Funding Information:
The authors acknowledge Larry Prokop, MLS, for his assistance in comprehensively searching several databases for the systematic review. The authors would like to acknowledge the Mayo Clinic Center for Clinical and Translational Science (CCaTS) for assistance with statistical analysis. This publication was supported by Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of Health.
Funding Information:
to acknowledge the Mayo Clinic Center for Clinical and Translational Science (CCaTS) for assistance with statistical analysis. This publication was supported by Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of Health.
Publisher Copyright:
© 2021 Royal Society Publishing. All rights reserved.
PY - 2021/7/1
Y1 - 2021/7/1
N2 - Objective The objective of this study is to describe the clinical presentation, tumor characteristics, natural history, and treatment patterns of sinonasal osteosarcoma. Methods Fourteen patients who had been treated for osteosarcoma of the nasal cavity and paranasal sinuses at a tertiary care center were reviewed. In addition, a systematic review of the literature for osteosarcoma of the sinonasal cavity was performed. Results In a systematic review, including 14 patients from the authors' institution, 53 total studies including 88 patients were assessed. Median follow-up was 18 months (interquartile range: 8-39 months). The most common presenting symptoms were facial mass or swelling (34%), and nasal obstruction (30%). The most common paranasal sinus involved by tumor was the maxillary sinus (64%), followed by the ethmoid sinuses (52%). The orbit (33%), dura (13%) and infratemporal fossa (10%) were the most common sites of local invasion. The majority of patients underwent surgery followed by adjuvant therapy (52.4%). Increasing age was associated with decreased overall survival rate (unit risk ratio [95% confidence interval (CI)] = 1.02 [1.003-1.043]; p = 0.0216) and T4 disease was associated with decreased disease-specific survival rate (hazard ratio [HR] = 2.87; p = 0.0495). The 2- and 5-year overall survival rates were 68 and 40%, respectively, while 2- and 5-year disease-specific survival rates were 71% and 44%, respectively. Conclusion Sinonasal osteosarcomas are uncommon tumors and can pose a significant therapeutic challenge. Increasing age and T4 disease are associated with worse prognosis. This disease usually warrants consultation by a multidisciplinary team and consideration of multimodality therapy.
AB - Objective The objective of this study is to describe the clinical presentation, tumor characteristics, natural history, and treatment patterns of sinonasal osteosarcoma. Methods Fourteen patients who had been treated for osteosarcoma of the nasal cavity and paranasal sinuses at a tertiary care center were reviewed. In addition, a systematic review of the literature for osteosarcoma of the sinonasal cavity was performed. Results In a systematic review, including 14 patients from the authors' institution, 53 total studies including 88 patients were assessed. Median follow-up was 18 months (interquartile range: 8-39 months). The most common presenting symptoms were facial mass or swelling (34%), and nasal obstruction (30%). The most common paranasal sinus involved by tumor was the maxillary sinus (64%), followed by the ethmoid sinuses (52%). The orbit (33%), dura (13%) and infratemporal fossa (10%) were the most common sites of local invasion. The majority of patients underwent surgery followed by adjuvant therapy (52.4%). Increasing age was associated with decreased overall survival rate (unit risk ratio [95% confidence interval (CI)] = 1.02 [1.003-1.043]; p = 0.0216) and T4 disease was associated with decreased disease-specific survival rate (hazard ratio [HR] = 2.87; p = 0.0495). The 2- and 5-year overall survival rates were 68 and 40%, respectively, while 2- and 5-year disease-specific survival rates were 71% and 44%, respectively. Conclusion Sinonasal osteosarcomas are uncommon tumors and can pose a significant therapeutic challenge. Increasing age and T4 disease are associated with worse prognosis. This disease usually warrants consultation by a multidisciplinary team and consideration of multimodality therapy.
KW - EEA
KW - expanded endonasal approach
KW - nasal cavity
KW - osteogenic sarcoma
KW - osteosarcoma
KW - paranasal sinuses
KW - sinonasal
UR - http://www.scopus.com/inward/record.url?scp=85111097044&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111097044&partnerID=8YFLogxK
U2 - 10.1055/s-0040-1701221
DO - 10.1055/s-0040-1701221
M3 - Review article
AN - SCOPUS:85111097044
SN - 2193-634X
VL - 82
SP - E138-E147
JO - Journal of Neurological Surgery, Part B: Skull Base
JF - Journal of Neurological Surgery, Part B: Skull Base
ER -